查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598503

经导管肺动脉瓣市场：按技术、原材料、应用和最终用途分类 - 全球预测 2025-2030

Transcatheter Pulmonary Valve Market by Technology, Raw Material, Application, End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年经导管肺动脉瓣市场估值为6353万美元，预计到2024年将达到6976万美元，复合年增长率为9.90%，到2030年将达到12308万美元。

经导管肺动脉瓣（TPV）市场包括无需开胸手术即可治疗先天性心臟疾病和肺动脉瓣闭锁不全的微创手术。其范围和定义包括透过基于导管的方法输送的人工瓣膜的设计和应用，为流出道先前已修復的患者提供治疗选择。这种需求源于对因禁忌症或高手术风险而无法进行外科瓣膜置换术的患者提供更安全、侵入性更小的解决方案的需求。最终用途主要用于患有先天性心臟疾病的儿科和成人患者，特别是那些先前修復的导管退化的患者。推动市场成长的关键因素包括先天性心臟疾病盛行率的增加、介入性心臟病学的进步以及对微创手术的日益偏好。阀门设计和材料的技术进步不仅带来了巨大的商机，而且随着人们对经导管治疗的认识不断提高，也带来了一个开拓的新兴市场。然而，高昂的程序成本、监管挑战以及某些地区的专业知识有限等限制因素阻碍了成长。此外，程序的复杂性以及需要长期资料来支持耐久性和有效性，这对市场扩张构成了进一步的挑战。创新领域包括开发更耐用和生物相容性材料、增强诊断成像技术以提高准确性以及将覆盖范围扩大到更广泛的解剖范围。此外，公司可以专注于上市后监督和利用真实资料进行迭代改进。 TPV 市场是一个充满活力的市场，受到循环系统领域持续的研发投资、策略联盟和收购的支持。市场参与者应利用与医疗保健提供者和监管机构的伙伴关係关係来克服挑战并利用对微创解决方案不断增长的需求。透过培育专注于以患者为中心的结果和具有成本效益的解决方案的创新生态系统，公司可以加强其市场定位并解决治疗领域的现有差距。

主要市场统计
基准年[2023] 6353万美元
预测年份 [2024] 6976万美元
预测年份 [2030] 12308万美元
复合年增长率（%） 9.90%

市场动态：快速发展的经导管肺动脉瓣市场的关键市场洞察

供需的动态交互作用正在改变经导管肺动脉瓣市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 各种心血管疾病的盛行率增加
    • 心臟瓣膜疾病人口不断增加，对肺动脉瓣置换术的需求迅速增加
    • 提高对经导管肺动脉瓣治疗的认识
  • 市场限制因素
    • 核准流程严格规定
  • 市场机会
    • 瓣膜置换术的技术进步
    • 与经导管心臟瓣膜技术相关的产品发布数量增加
  • 市场挑战
    • 替代技术的可用性

波特的五力：驾驭经导管肺动脉瓣市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解经导管肺动脉瓣市场的外部影响

外部宏观环境因素在塑造经导管肺动脉瓣市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解经导管肺动脉瓣市场的竞争格局

经导管肺动脉瓣市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵经导管肺动脉瓣市场供应商的绩效评估

FPNV 定位矩阵是评估经导管肺动脉瓣市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製经导管肺动脉瓣市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对经导管肺动脉瓣市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 各种心血管疾病的盛行率增加
      • 心臟瓣膜疾病患者数量不断增加，肺动脉瓣置换需求快速成长
      • 提高对经导管肺动脉瓣治疗的认识
    • 抑制因素
      • 核准流程严格规定
    • 机会
      • 瓣膜置换手术的技术进步
      • 增加经导管心臟瓣膜技术相关的产品发布
    • 任务
      • 替代技术的可用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章经导管肺动脉瓣市场：依技术分类

  • 球囊扩张型经导管瓣膜
  • 自膨胀式经导管瓣膜

第七章经导管肺动脉瓣市场：依原料分类

  • 合成经导管瓣膜
  • 组织工程经导管瓣膜

第八章经导管肺动脉瓣市场：依应用分类

  • 心臟异常
  • 肺动脉闭锁
  • 肺逆流症
  • 肺动脉狭窄
  • 法洛氏四合症
  • 动脉干

第九章经导管肺动脉瓣市场：依最终用途分类

  • 成人用
  • 小儿科

第10章美洲经导管肺动脉瓣市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太经导管肺动脉瓣市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲经导管肺动脉瓣市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Boston Scientific Corporation
  • Colibri Heart Valve, LLC
  • Commonwealth Edison Company
  • CryoLife, Inc.
  • Direct Flow Medical, Inc.
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • Jude Medical Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • SYMETIS
  • ValveXchange, Inc.
  • Venus MedTech HangZhou Inc
  • Xeltis AG
Product Code: MRR-03168519576D

The Transcatheter Pulmonary Valve Market was valued at USD 63.53 million in 2023, expected to reach USD 69.76 million in 2024, and is projected to grow at a CAGR of 9.90%, to USD 123.08 million by 2030.

The Transcatheter Pulmonary Valve (TPV) market involves minimally invasive procedures to treat congenital heart defects and pulmonary valve dysfunction without open-heart surgery. Scope and definition encompass the design and application of prosthetic valves delivered via catheter-based methods, offering therapeutic alternatives for patients with previously repaired outflow tracts. Necessity stems from the demand for safer, less invasive solutions for patients inadequately served by surgical valve replacement due to contraindications or high surgical risk. End-use applications primarily lie within pediatric and adult populations with congenital heart defects, particularly benefiting those with previously repaired conduits experiencing degeneration. Key market growth influencers include the increasing prevalence of congenital heart diseases, advances in interventional cardiology, and a growing preference for minimally invasive procedures. Technological advancements in valve design and materials present significant opportunities, as well as untapped emerging markets with a rising awareness of transcatheter therapies. However, limitations such as high procedural costs, regulatory challenges, and limited expertise in certain regions pose growth barriers. Moreover, procedural complexities and the need for long-term data to support durability and effectiveness further challenge market expansion. Areas ripe for innovation include the development of more durable and biocompatible materials, enhanced imaging techniques for precision, and novel delivery mechanisms that expand application reach to broader anatomical considerations. Additionally, companies could focus on post-market surveillance and iterative improvements driven by real-world data. The TPV market is dynamic, supported by continuous R&D investments, strategic collaborations, and acquisitions in the cardiovascular space. Market players should leverage partnerships with healthcare providers and regulatory bodies to navigate challenges and capitalize on the burgeoning demand for minimally invasive solutions. By fostering an innovative ecosystem focused on patient-centric outcomes and cost-effective solutions, companies can strengthen their market positioning and address existing gaps in the treatment landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 63.53 million
Estimated Year [2024] USD 69.76 million
Forecast Year [2030] USD 123.08 million
CAGR (%) 9.90%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transcatheter Pulmonary Valve Market

The Transcatheter Pulmonary Valve Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of various cardiovascular diseases
    • Growing population with heart valve disorders and surging demand for pulmonary valve replacement
    • Increasing awareness of transcatheter pulmonary valve therapy
  • Market Restraints
    • Stringent regulations for approval process
  • Market Opportunities
    • Technological advancement in valve replacement procedures
    • Growing number of product launches related to transcatheter heart valve technologies
  • Market Challenges
    • The availability of alternative technologies

Porter's Five Forces: A Strategic Tool for Navigating the Transcatheter Pulmonary Valve Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transcatheter Pulmonary Valve Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transcatheter Pulmonary Valve Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transcatheter Pulmonary Valve Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transcatheter Pulmonary Valve Market

A detailed market share analysis in the Transcatheter Pulmonary Valve Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transcatheter Pulmonary Valve Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transcatheter Pulmonary Valve Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Transcatheter Pulmonary Valve Market

A strategic analysis of the Transcatheter Pulmonary Valve Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transcatheter Pulmonary Valve Market, highlighting leading vendors and their innovative profiles. These include Boston Scientific Corporation, Colibri Heart Valve, LLC, Commonwealth Edison Company, CryoLife, Inc., Direct Flow Medical, Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., Jude Medical Inc., Lepu Medical Technology (Beijing) Co., Ltd., LivaNova PLC, Medtronic PLC, SYMETIS, ValveXchange, Inc., Venus MedTech HangZhou Inc, and Xeltis AG.

Market Segmentation & Coverage

This research report categorizes the Transcatheter Pulmonary Valve Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Balloon-Expanded Transcatheter Valve and Self-Expanded Transcatheter Valve.
  • Based on Raw Material, market is studied across Synthetic Transcatheter Valve and Tissue Engineered Transcatheter Valve.
  • Based on Application, market is studied across Cardiac Anomaly, Pulmonary Atresia, Pulmonary Regurgitation, Pulmonary Stenosis, Tetralogy Of Fallot, and Truncus Arteriosus.
  • Based on End Use, market is studied across Adult and Pediatric.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of various cardiovascular diseases
      • 5.1.1.2. Growing population with heart valve disorders and surging demand for pulmonary valve replacement
      • 5.1.1.3. Increasing awareness of transcatheter pulmonary valve therapy
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations for approval process
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in valve replacement procedures
      • 5.1.3.2. Growing number of product launches related to transcatheter heart valve technologies
    • 5.1.4. Challenges
      • 5.1.4.1. The availability of alternative technologies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transcatheter Pulmonary Valve Market, by Technology

  • 6.1. Introduction
  • 6.2. Balloon-Expanded Transcatheter Valve
  • 6.3. Self-Expanded Transcatheter Valve

7. Transcatheter Pulmonary Valve Market, by Raw Material

  • 7.1. Introduction
  • 7.2. Synthetic Transcatheter Valve
  • 7.3. Tissue Engineered Transcatheter Valve

8. Transcatheter Pulmonary Valve Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiac Anomaly
  • 8.3. Pulmonary Atresia
  • 8.4. Pulmonary Regurgitation
  • 8.5. Pulmonary Stenosis
  • 8.6. Tetralogy Of Fallot
  • 8.7. Truncus Arteriosus

9. Transcatheter Pulmonary Valve Market, by End Use

  • 9.1. Introduction
  • 9.2. Adult
  • 9.3. Pediatric

10. Americas Transcatheter Pulmonary Valve Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Transcatheter Pulmonary Valve Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Transcatheter Pulmonary Valve Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Boston Scientific Corporation
  • 2. Colibri Heart Valve, LLC
  • 3. Commonwealth Edison Company
  • 4. CryoLife, Inc.
  • 5. Direct Flow Medical, Inc.
  • 6. Edwards Lifesciences Corporation
  • 7. JenaValve Technology, Inc.
  • 8. Jude Medical Inc.
  • 9. Lepu Medical Technology (Beijing) Co., Ltd.
  • 10. LivaNova PLC
  • 11. Medtronic PLC
  • 12. SYMETIS
  • 13. ValveXchange, Inc.
  • 14. Venus MedTech HangZhou Inc
  • 15. Xeltis AG

LIST OF FIGURES

  • FIGURE 1. TRANSCATHETER PULMONARY VALVE MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. TRANSCATHETER PULMONARY VALVE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. TRANSCATHETER PULMONARY VALVE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSCATHETER PULMONARY VALVE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSCATHETER PULMONARY VALVE MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY BALLOON-EXPANDED TRANSCATHETER VALVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY SELF-EXPANDED TRANSCATHETER VALVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY SYNTHETIC TRANSCATHETER VALVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TISSUE ENGINEERED TRANSCATHETER VALVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY CARDIAC ANOMALY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PULMONARY ATRESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PULMONARY REGURGITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PULMONARY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TETRALOGY OF FALLOT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TRUNCUS ARTERIOSUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 191. TRANSCATHETER PULMONARY VALVE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. TRANSCATHETER PULMONARY VALVE MARKET, FPNV POSITIONING MATRIX, 2023